Strong Q4 2024 Financial Performance and 2025 Outlook
February 6, 2025 - 17:33
In the fourth quarter of 2024, the company reported a remarkable 45% increase in revenue, reaching $13.53 billion. This surge was primarily fueled by significant volume growth from its flagship products, Mounjaro and Zepbound. The performance in this quarter showcases the company's robust market presence and the effectiveness of its growth strategies.
Additionally, non-incretin revenue experienced a solid 20% increase compared to the same period in 2023, reflecting the company's diverse portfolio and successful expansion into new therapeutic areas. The strong financial results indicate not only the popularity of its current offerings but also the potential for future growth.
Looking ahead, the company has provided guidance for 2025, emphasizing its commitment to innovation and market leadership. With a focus on enhancing product accessibility and exploring new opportunities, the company is well-positioned to sustain its momentum and deliver continued value to stakeholders in the coming year.
MORE NEWS
May 3, 2026 - 19:02
Is Wingstop Inc. (WING) A Good Stock To Buy Now?A new bullish thesis on Wingstop Inc. has surfaced, this time from Aalim Azeez Ur Rehman on the Saadiyat Capital Substack. The analysis makes a case for why the chicken wing chain might still have...
May 3, 2026 - 06:24
Pivotal Research Raises Alphabet (GOOGL) Price Target, Keeps Buy RatingPivotal Research raised its price target on Alphabet Inc. (NASDAQ:GOOGL) from $420 to $470 on April 30, while keeping a Buy rating on the stock. The firm cited the company`s first-quarter earnings...
May 2, 2026 - 18:41
Welltower Q1 Earnings Call HighlightsWelltower (NYSE:WELL) reported a robust first quarter for 2026, with executives citing record growth in same-store net operating income and ongoing improvements in operating margins across its...
May 2, 2026 - 03:34
Directors’ Deals: Costain’s finance chief sells after deferred share awardThe finance director of Costain has sold a tranche of shares in the construction and infrastructure group, just weeks after a deferred share award vested. The disposal, which was disclosed in a...